| Drug Type Monoclonal antibody | 
| Synonyms DC859A series, Research programme: anticancer therapeutics - Demuris | 
| Target | 
| Action inhibitors | 
| Mechanism FOXO1 inhibitors(Forkhead box protein O1 inhibitors), FOXO3 inhibitors(forkhead box O3 inhibitors) | 
| Therapeutic Areas | 
| Active Indication- | 
| Inactive Indication | 
| Originator Organization | 
| Active Organization- | 
| Inactive Organization | 
| License Organization- | 
| Drug Highest PhasePendingDiscovery | 
| First Approval Date- | 
| Regulation- | 
| Indication | Highest Phase | Country/Location | Organization | Date | 
|---|---|---|---|---|
| Acute Myeloid Leukemia | Discovery | United Kingdom  | 01 Aug 2019 | 






